Pathologic responses and surgical outcomes after neoadjuvant immunochemotherapy versus neoadjuvant chemoradiotherapy in patients with locally advanced esophageal squamous cell carcinoma

Pathologic responses and surgical outcomes after neoadjuvant immunochemotherapy versus neoadjuvant chemoradiotherapy in patients with locally advanced esophageal squamous cell carcinoma

BackgroundCurrently, the role of immunotherapy in neoadjuvant setting for patients with locally advanced esophageal squamous cell carcinoma (ESCC) is gradually attracting attention. Few studies compared the efficacy of neoadjuvant immunochemotherapy (NICT) and neoadjuvant chemoradiotherapy (NCRT). O...

Full description

Bibliographic Details
Main Authors: Lei Xu, Xiu-feng Wei, Can-jun Li, Zhao-yang Yang, Yong-kui Yu, Hao-miao Li, Hou-nai Xie, Ya-fan Yang, Wei-wei Jing, Zhen Wang, Xiao-zheng Kang, Rui-xiang Zhang, Jian-jun Qin, Li-yan Xue, Nan Bi, Xian-kai Chen, Yin Li
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-11-01
Series:Frontiers in Immunology
Subjects:
neoadjuvant immunotherapy
immunochemotherapy
neoadjuvant chemoradiotherapy
treatment response
postoperative complications
esophageal squamous cell carcinoma
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2022.1052542/full

Internet

https://www.frontiersin.org/articles/10.3389/fimmu.2022.1052542/full

Similar Items